PubMed:7191069 JSONTXT

{"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":49},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":50,"end":139},"obj":"Sentence"},{"id":"TextSentencer_T3","span":{"begin":140,"end":282},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":49},"obj":"Sentence"},{"id":"T2","span":{"begin":50,"end":139},"obj":"Sentence"},{"id":"T3","span":{"begin":140,"end":282},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Heterozygous C2-deficiency and myasthenia gravis.\nComplement deficiency states in myasthenia gravis (MG) have not been reported previously. We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family."}

{"project":"PubCasesHPO","denotations":[{"id":"AB1","span":{"begin":50,"end":71},"obj":"HP:0004431"}],"text":"Heterozygous C2-deficiency and myasthenia gravis.\nComplement deficiency states in myasthenia gravis (MG) have not been reported previously. We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family."}

{"project":"PubCasesORDO","denotations":[{"id":"TI1","span":{"begin":31,"end":48},"obj":"ORDO:589"},{"id":"AB1","span":{"begin":82,"end":99},"obj":"ORDO:589"}],"namespaces":[{"prefix":"ORDO","uri":"http://www.orpha.net/ORDO/Orphanet_"}],"text":"Heterozygous C2-deficiency and myasthenia gravis.\nComplement deficiency states in myasthenia gravis (MG) have not been reported previously. We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family."}

{"project":"NCBIDiseaseCorpus","denotations":[{"id":"T1","span":{"begin":13,"end":26},"obj":"SpecificDisease:OMIM:217000"},{"id":"T2","span":{"begin":31,"end":48},"obj":"SpecificDisease:D009157"},{"id":"T3","span":{"begin":50,"end":71},"obj":"Modifier:D007153"},{"id":"T4","span":{"begin":82,"end":99},"obj":"SpecificDisease:D009157"},{"id":"T5","span":{"begin":101,"end":103},"obj":"SpecificDisease:D009157"},{"id":"T6","span":{"begin":185,"end":187},"obj":"SpecificDisease:D009157"},{"id":"T7","span":{"begin":205,"end":218},"obj":"SpecificDisease:OMIM:217000"}],"text":"Heterozygous C2-deficiency and myasthenia gravis.\nComplement deficiency states in myasthenia gravis (MG) have not been reported previously. We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family."}

{"project":"NCBI-Disease-Train","denotations":[{"id":"T4362","span":{"begin":13,"end":26},"obj":"SpecificDisease"},{"id":"T4363","span":{"begin":31,"end":48},"obj":"SpecificDisease"},{"id":"T4364","span":{"begin":50,"end":71},"obj":"Modifier"},{"id":"T4365","span":{"begin":82,"end":99},"obj":"SpecificDisease"},{"id":"T4366","span":{"begin":101,"end":103},"obj":"SpecificDisease"},{"id":"T4367","span":{"begin":185,"end":187},"obj":"SpecificDisease"},{"id":"T4368","span":{"begin":205,"end":218},"obj":"SpecificDisease"}],"attributes":[{"id":"A4362","pred":"database_id","subj":"T4362","obj":"OMIM:217000"},{"id":"A4363","pred":"database_id","subj":"T4363","obj":"D009157"},{"id":"A4364","pred":"database_id","subj":"T4364","obj":"D007153"},{"id":"A4365","pred":"database_id","subj":"T4365","obj":"D009157"},{"id":"A4366","pred":"database_id","subj":"T4366","obj":"D009157"},{"id":"A4367","pred":"database_id","subj":"T4367","obj":"D009157"},{"id":"A4368","pred":"database_id","subj":"T4368","obj":"OMIM:217000"}],"text":"Heterozygous C2-deficiency and myasthenia gravis.\nComplement deficiency states in myasthenia gravis (MG) have not been reported previously. We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family."}

{"project":"NCBI-Disease-Corpus-All","denotations":[{"id":"T4362","span":{"begin":13,"end":26},"obj":"SpecificDisease"},{"id":"T4363","span":{"begin":31,"end":48},"obj":"SpecificDisease"},{"id":"T4364","span":{"begin":50,"end":71},"obj":"Modifier"},{"id":"T4365","span":{"begin":82,"end":99},"obj":"SpecificDisease"},{"id":"T4366","span":{"begin":101,"end":103},"obj":"SpecificDisease"},{"id":"T4367","span":{"begin":185,"end":187},"obj":"SpecificDisease"},{"id":"T4368","span":{"begin":205,"end":218},"obj":"SpecificDisease"}],"attributes":[{"id":"A4362","pred":"database_id","subj":"T4362","obj":"OMIM:217000"},{"id":"A4363","pred":"database_id","subj":"T4363","obj":"D009157"},{"id":"A4364","pred":"database_id","subj":"T4364","obj":"D007153"},{"id":"A4365","pred":"database_id","subj":"T4365","obj":"D009157"},{"id":"A4366","pred":"database_id","subj":"T4366","obj":"D009157"},{"id":"A4367","pred":"database_id","subj":"T4367","obj":"D009157"},{"id":"A4368","pred":"database_id","subj":"T4368","obj":"OMIM:217000"}],"text":"Heterozygous C2-deficiency and myasthenia gravis.\nComplement deficiency states in myasthenia gravis (MG) have not been reported previously. We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family."}

{"project":"NCBI-Disease-Corpus-2stage-All","denotations":[{"id":"T1","span":{"begin":31,"end":48},"obj":"SpecificDisease"},{"id":"T2","span":{"begin":82,"end":99},"obj":"SpecificDisease"},{"id":"T3","span":{"begin":101,"end":103},"obj":"SpecificDisease"},{"id":"T4","span":{"begin":185,"end":187},"obj":"SpecificDisease"}],"text":"Heterozygous C2-deficiency and myasthenia gravis.\nComplement deficiency states in myasthenia gravis (MG) have not been reported previously. We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family."}

{"project":"NCBI-Disease-Corpus-rezarta-All","denotations":[{"id":"T1","span":{"begin":13,"end":26},"obj":"SpecificDisease"},{"id":"T2","span":{"begin":31,"end":48},"obj":"SpecificDisease"},{"id":"T3","span":{"begin":82,"end":99},"obj":"SpecificDisease"},{"id":"T4","span":{"begin":101,"end":103},"obj":"SpecificDisease"},{"id":"T5","span":{"begin":185,"end":187},"obj":"SpecificDisease"},{"id":"T6","span":{"begin":205,"end":218},"obj":"SpecificDisease"}],"text":"Heterozygous C2-deficiency and myasthenia gravis.\nComplement deficiency states in myasthenia gravis (MG) have not been reported previously. We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family."}

{"project":"NCBI-Disease-Corpus-4oGuideline-All","denotations":[{"id":"T1","span":{"begin":13,"end":26},"obj":"SpecificDisease"},{"id":"T2","span":{"begin":31,"end":48},"obj":"SpecificDisease"},{"id":"T3","span":{"begin":82,"end":99},"obj":"Modifier"},{"id":"T4","span":{"begin":185,"end":187},"obj":"SpecificDisease"},{"id":"T5","span":{"begin":192,"end":218},"obj":"SpecificDisease"}],"text":"Heterozygous C2-deficiency and myasthenia gravis.\nComplement deficiency states in myasthenia gravis (MG) have not been reported previously. We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family."}

{"project":"NCBI-Disease-Corpus-Simple-All","denotations":[{"id":"T1","span":{"begin":0,"end":48},"obj":"CompositeMention"},{"id":"T2","span":{"begin":50,"end":78},"obj":"DiseaseClass"},{"id":"T3","span":{"begin":82,"end":104},"obj":"SpecificDisease"},{"id":"T4","span":{"begin":185,"end":187},"obj":"SpecificDisease"},{"id":"T5","span":{"begin":192,"end":218},"obj":"CompositeMention"}],"text":"Heterozygous C2-deficiency and myasthenia gravis.\nComplement deficiency states in myasthenia gravis (MG) have not been reported previously. We describe a 19-year-old woman with typical MG and heterozygous C2 deficiency, along with HLA typing of the patient and her immediate family."}